UBS Reduces PT on McCormick & Company (MKC) Stock

Core Viewpoint - McCormick & Company, Incorporated (NYSE:MKC) is facing challenges as its Q4 2025 EPS fell short of estimates, leading UBS to lower its price target to $67 from $70 while maintaining a "Neutral" rating [1]. Financial Performance - For Q4 2025, McCormick reported net sales of $1,850.4 million, reflecting a 3% year-over-year increase, which included a 1% favorable impact from currency [2]. - The company anticipates net sales growth of 13% to 17% for FY 2026 [2]. Strategic Initiatives - McCormick is leveraging its competitive advantages, productivity initiatives, and cost management strategies to navigate headwinds and rising costs [3]. - The company is focused on brand investment, distribution expansion, and innovation across its product portfolio [2].